# The Breath-2 Trial

> **NCT05149872** · PHASE4 · COMPLETED · sponsor: **Leiden University Medical Center** · enrollment: 35 (actual)

## Conditions studied

- Peripheral Chemosensitivity

## Interventions

- **OTHER:** Muscle relaxation
- **OTHER:** Reversal

## Key facts

- **NCT ID:** NCT05149872
- **Lead sponsor:** Leiden University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-08-15
- **Primary completion:** 2022-11-01
- **Final completion:** 2023-04-01
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2025-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05149872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05149872, "The Breath-2 Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05149872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*